🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/01/1994 | 16,88 | 17,18 | 16,88 | 17,12 | +0,35% | 1,77% | 5.677.226 |
| 25/01/1994 | 16,64 | 17,12 | 16,58 | 17,06 | +2,88% | 3,23% | 8.600.098 |
| 24/01/1994 | 16,70 | 16,82 | 16,46 | 16,58 | -1,07% | 2,14% | 6.323.842 |
| 21/01/1994 | 16,94 | 17,00 | 16,34 | 16,76 | -1,75% | 3,87% | 7.168.949 |
| 20/01/1994 | 17,00 | 17,12 | 16,88 | 17,06 | -0,35% | 1,40% | 6.127.237 |
| 19/01/1994 | 17,41 | 17,47 | 16,94 | 17,12 | -2,05% | 3,08% | 9.641.181 |
| 18/01/1994 | 17,47 | 17,71 | 17,41 | 17,47 | +0,34% | 1,71% | 5.874.040 |
| 17/01/1994 | 17,35 | 17,53 | 17,29 | 17,41 | +0,00% | 1,37% | 3.936.917 |
| 14/01/1994 | 17,47 | 17,65 | 17,29 | 17,41 | -0,34% | 2,05% | 4.759.806 |
| 13/01/1994 | 17,41 | 17,53 | 17,35 | 17,47 | +0,00% | 1,03% | 3.682.462 |
| 12/01/1994 | 17,71 | 17,71 | 17,41 | 17,47 | -1,35% | 1,68% | 5.160.352 |
| 11/01/1994 | 17,89 | 17,89 | 17,53 | 17,71 | -1,00% | 2,00% | 5.256.978 |
| 10/01/1994 | 17,77 | 17,95 | 17,59 | 17,89 | +1,01% | 2,01% | 6.402.861 |
| 07/01/1994 | 17,59 | 17,77 | 17,35 | 17,71 | +1,36% | 2,37% | 7.269.766 |
| 06/01/1994 | 17,83 | 17,89 | 17,41 | 17,47 | -1,68% | 2,68% | 8.273.331 |
| 05/01/1994 | 17,24 | 18,13 | 17,18 | 17,77 | +3,47% | 5,54% | 23.320.096 |
| 04/01/1994 | 17,00 | 17,24 | 16,88 | 17,18 | +2,13% | 2,11% | 7.748.493 |
| 03/01/1994 | 16,58 | 16,94 | 16,52 | 16,82 | +2,55% | 2,52% | 7.951.176 |
| 31/12/1993 | 16,52 | 16,58 | 16,40 | 16,40 | -1,08% | 1,08% | 4.289.883 |
| 30/12/1993 | 16,70 | 16,76 | 16,58 | 16,58 | -1,07% | 1,07% | 4.078.397 |
| 29/12/1993 | 16,94 | 17,00 | 16,58 | 16,76 | -0,35% | 2,47% | 6.414.389 |
| 28/12/1993 | 16,76 | 17,00 | 16,70 | 16,82 | +0,00% | 1,78% | 7.594.437 |
| 27/12/1993 | 16,52 | 16,82 | 16,46 | 16,82 | +2,92% | 2,17% | 7.718.101 |
| 23/12/1993 | 16,40 | 16,64 | 16,28 | 16,34 | +0,37% | 2,18% | 6.404.538 |
| 22/12/1993 | 16,34 | 16,40 | 16,10 | 16,28 | +0,37% | 1,82% | 6.177.541 |
| 21/12/1993 | 16,22 | 16,34 | 16,16 | 16,22 | +0,37% | 1,10% | 5.543.920 |
| 20/12/1993 | 16,16 | 16,28 | 16,04 | 16,16 | +0,74% | 1,48% | 6.921.621 |
| 17/12/1993 | 15,86 | 16,16 | 15,80 | 16,04 | +1,51% | 2,26% | 9.835.061 |
| 16/12/1993 | 15,80 | 15,86 | 15,68 | 15,80 | +0,76% | 1,13% | 5.980.517 |
| 15/12/1993 | 15,63 | 15,86 | 15,57 | 15,68 | +0,77% | 1,91% | 7.509.549 |